Kaj Blennow (Former)
1 – 10 of 264
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort
- Contribution to journal › Article
-
Mark
Blood biomarkers for the prediction of outcome after cardiac arrest : an international prospective observational study within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial
- Contribution to journal › Article
-
Mark
Fluid biomarkers for neurodegenerative diseases : a comprehensive update
- Contribution to journal › Scientific review
- 2025
-
Mark
Plasma neurofilament light chain is increased in Niemann-Pick Type C but glial fibrillary acidic protein remains normal
- Contribution to journal › Article
-
Mark
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
Neurofilament, but not Alzheimer disease biomarkers in the acute phase correlate with cognitive performance after cardiac arrest
- Contribution to journal › Article
-
Mark
Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's disease
- Contribution to journal › Article
-
Mark
The CentiMarker project : Standardizing quantitative Alzheimer's disease fluid biomarkers for biologic interpretation
- Contribution to journal › Article
-
Mark
A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease
- Contribution to journal › Article
-
Mark
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study
- Contribution to journal › Article
